{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":21,"n_cols":5,"rows_kept":21,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[11,2,11,3],[12,2,12,3],[16,2,16,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910455930603321"]
[null,null,"Titolo",null,"Pharmaceutical dosage forms Tablets"]
[null,null,"Pubbl/distr/stampa",null,"New York : , : Informa Healthcare USA, , 2008"]
[null,null,"ISBN",null,"0-429-19115-4"]
[{"$nulls":4},"1-4200-2029-3"]
[null,null,"Edizione",null,"[3rd ed. /]"]
[null,null,"Descrizione fisica",null,"1 online resource (550 p.)"]
[null,null,"Disciplina",null,"615/.1901"]
[null,null,"Soggetti",null,"Tablets (Medicine)"]
[{"$nulls":4},"Drugs - Dosage forms"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Front Cover; Foreword; Preface; Contents; Contributors; Chapter 1. Mass Transfer from Solid Oral Dosage Forms; Chapter 2. Approaches for Improving Bioavailability of Poorly Soluble Drugs; Chapter 3. Aims and Objectives and of Experimental Design and Optimization in Formulation and Process Development; Chapter 4. Knowledge-based Systems and Other AI Applications for Tableting; Chapter 5. Direct Compression and the Role of Filler-binders; Chapter 6. Disintegrants in Tableting; Chapter 7. Lubricants, Glidants, and Antiadherents; Chapter 8. Surfactants and Colors in Tablets"]
[{"$nulls":4},"Chapter 9. Orally Disintegrating Tablets and Related Tablet FormulationsChapter 10. Formulation Challenges: Multiple Vitamin and Mineral Dosage Forms; Chapter 11. Botanicals and Their Formulation into Oral Solid Dosage Forms; Chapter 12. Formulation of Specialty Tablets for Slow Oral Dissolution; Chapter 13. Formulation and Design of Veterinary Tablets; Chapter 14. Swellable and Rigid Matrices: Controlled Release Matrices with Cellulose Ethers; Chapter 15. Carrageenans in Solid Dosage Form Design; Chapter 16. Osmotic Systems; Chapter 17. Tableting of Multiparticulate Modified Release Systems"]
[{"$nulls":4},"Back Cover"]
[null,null,null,"Sommario/riassunto","<b><i>Pharmaceutical Dosage Forms: Tablets, Third Edition</i></b>is acomprehensive treatment of the design, formulation, manufacture, and evaluation of the tablet dosage form.  The ultimate goal of drug product development is to design a system "]
[{"$nulls":4},"that maximizes the therapeutic potential of the drug substance and facilitates its access to patients; <b><i>Volume 2</i></b> focuses on the rational design, and formulation of a tablet and includes chapters with practical illustrations and formulation examples."]